EphA2 is a therapy target in EphA2-positive leukemias but is not essential for normal hematopoiesis or leukemia

Sara Charmsaz, Kirrilee Beckett, Fiona M. Smith, Claudia Bruedigam, Andrew S. Moore, Fares Al-Ejeh, Steven W. Lane, Andrew W. Boyd

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)

Fingerprint

Dive into the research topics of 'EphA2 is a therapy target in EphA2-positive leukemias but is not essential for normal hematopoiesis or leukemia'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science